ArticleArthritis research & therapy2026
Sleep quality, duration, and multi-trajectories as predictors of rheumatoid arthritis: evidence from the english longitudinal study of ageing.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) is a prevalent chronic autoimmune disease associated with substantial disability as well as socioeconomic burden. Emerging evidence suggests that sleep disturbances may increase RA risk, yet the roles of sleep quality, sleep duration, as well as their long-term patterns remain unclear. Depression—a key psychoneuroimmunological factor—may mediate this association. The research aimed to explore the relationships of sleep quality (SQ), sleep duration (SD) and incident RA, as well as to explore the mediating role of depressive symptoms as well as the effects of long-term sleep trajectories.
methodsData were obtained from the English Longitudinal Study of Ageing (ELSA), including adults free of RA at baseline. Cox proportional hazards models were employed to estimate the connection of SQ and SD with incident RA, adjusting for demographic, lifestyle, and health-related factors. Mediation analysis quantified the indirect effects of depressive symptoms. Group-based multi-trajectory modeling (GBMTM) was further applied to identify joint trajectories of SQ and SD and assess their connection with RA risk.
resultsDuring follow-up, 607 participants developed RA. Compared with those reporting good SQ, individuals with moderate (HR = 1.23, 95% CI: 1.02–1.48) or poor (HR = 1.50, 95% CI: 1.20–1.87) SQ had a significantly higher risk of RA. A linear connection was observed between shorter SD and increased RA risk, with each 1-hour reduction in sleep related with approximately 7% higher risk (HR = 1.07, 95% CI: 1.01–1.17). Depression partially mediated the associations between SQ, SD, and RA risk, accounting for about 40% and 44% of the total effects, respectively. GBMTM identified three distinct sleep trajectory groups, with the “persistently poor-quality/short-sleep” trajectory showing the highest RA risk (OR = 1.70, 95% CI: 1.11–2.56).
conclusionPoor SQ and shorter SD are independently related with an elevated risk of RA among middle-aged and older adults, partly mediated by depression. Persistent adverse sleep patterns confer cumulative risk, highlighting the potential of sleep and mood management as modifiable targets for primary prevention of RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.